Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.38 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.34 |
| ▸ | ESR1 | P03372 | 6/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | ESRRG | P62508 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4056336 | 0.85 | ESR1 (0.43) | CYP1A2CYP2D6CYP2C19NUDT1BACE1 | |
| SCHEMBL4061548 | 0.82 | NUDT1 (0.44) | CYP2D6NUDT1BACE1CYP2C9ESR2 | |
| SCHEMBL4058701 | 0.80 | ALOX15 (0.50) | HSD17B10TSHRESR2ESR1CYP3A4 | |
| SCHEMBL8141767 | 0.80 | NUDT1 (0.40) | NUDT1BACE1ESR2ESR1NPC1 | |
| SCHEMBL11413208 | 0.79 | CYP2C19 (0.49) | CYP1A2CYP2D6CYP2C19NUDT1BACE1 | |
| SCHEMBL2545354 | 0.79 | AMY1A (0.50) | CYP1A2CYP2D6CYP2C19NUDT1BACE1 | |
| SCHEMBL9655970 | 0.79 | KDM4E (0.42) | CYP1A2CYP2D6CYP2C19NUDT1BACE1 | |
| SCHEMBL8142469 | 0.79 | NUDT1 (0.39) | NUDT1BACE1ESR2ESR1NPC1 | |
| SCHEMBL2386130 | 0.79 | SHBG (0.43) | CYP1A2CYP2D6CYP2C19NUDT1BACE1 | |
| SCHEMBL2385696 | 0.79 | NUDT1 (0.39) | CYP2C19NUDT1BACE1CYP2C9ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | CYP1A2 1607/4885CYP2D6 2877/4885CYP2C19 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.